USE OF 7-(2-OXA-5,8-DIAZABICYCLO[4.3.0]NON-8-YL)-QUINOLONECARBOXYLICACID AND -NAPHTHYRIDONECARBOXYLICACID DERIVATIVES FOR THE THERAPY OFHELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISORDERS ASSOCIATED THEREWITH

摘要

The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives of the general formula (I), which are substituted in the 7-position by a 2- oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith <IMG>